24 results
Thumbnail

D1.496 - Variation in platelet-activating factor levels among patients with chronic spontaneous urticaria

Thumbnail

D1.507 - Biomarkers of T2-airway inflammation in patients with asthma and COPD overlap

Thumbnail

D1.498 - Altered B Cell Dynamics in Childhood-Onset Systemic Lupus Erythematosus: Insights from Disease States and Rituximab Treatment

Thumbnail

D1.504 - Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: Clinical Characteristics and Outcomes in a series of pediatric cases

Thumbnail

D1.506 - Mast cell activation and type 2 inflammation in heart failure with preserved ejection fraction: a pilot cross-sectional study

Thumbnail

D1.508 - Assessment of automated serum sIgG testing for key bacterial pathogens in Cystic Fibrosis

Thumbnail

D1.510 - Fecal Calprotectin as a Marker for Differentiating Children with Atopic Dermatitis With and Without Food Allergy

Thumbnail

D1.511 - Hereditary alpha-tryptasemia in chronic spontaneous urticaria: prevalence and clinical impact

Thumbnail

D1.513 - Reduced Expression of PDCD4 on CD14+ Monocytes Correlates with Inflammatory Severity in Neonatal Sepsis: A Pilot Study

Thumbnail

D3.308 - Kounis Syndrome: the allergic myocardial infarction

Thumbnail

D3.313 - Recurrent Anaphylaxis with Elevated Baseline Tryptase Revealing Hereditary Alpha-Tryptasemia with Mast Cell Activation

Thumbnail

D3.318 - Evaluation of Clinical Predictors and Serum Tryptase Levels in Systemic Mastocytosis

Thumbnail

D3.319 - Clinical Data of Drug Induced Anaphylaxis according to the standardized European Anaphylaxis Registry (NORA)

Thumbnail

D3.320 - Anaphylaxis by Chlorhexidine: A case series

Thumbnail

D3.321 - Cardiac arrest after Iodixanol: a case of non-IgE mediated mast cell activation

Thumbnail

D3.307 - Chlorhexidine-triggered anaphylaxis in a child with multisystem allergy and sickle cell disease: a diagnostic pitfall

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria